TORL Biotherapeutics LLC announced that it will receive $158,300,000 in funding on April 4, 2024. The company will issue membership units in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.94 USD | -1.57% | -10.31% | -14.36% |
Apr. 30 | Global markets live: Adidas, Mercedes, McDonalds, Eli Lilly, PayPal, MicroStrategy, Tesla... | |
Apr. 30 | A flurry of corporate results ahead of the Fed's rate decision |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.36% | 90.49B | |
+34.00% | 664B | |
+29.29% | 567B | |
-7.75% | 354B | |
+18.53% | 330B | |
+4.95% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.89% | 148B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- TORL BioTherapeutics LLC announced that it expects to receive $158.3 million in funding